Exemplar Genetics

Sioux Center, United States Founded: 2008 • Age: 18 yrs Acquired By Precigen
Genetic miniature pig models are developed for disease research.
Annual revenue - Latest available
Total funding - 14 rounds
Employees 33 Tracked headcount
Investors 3 Known backers
Products 5 Services tracked
Competitors 11 Brand Intelligence

About Exemplar Genetics

Exemplar Genetics is a company based in Sioux Center (United States) founded in 2008 was acquired by Precigen in January 2015. The company has 33 employees as of December 31, 2022. Exemplar Genetics offers products and services including Gene-edited Minipigs, Custom Models, Characterization Services, Housing Services, and Preclinical Services. Exemplar Genetics operates in a competitive market with competitors including Biocytogen, Interius Biotherapeutics, Applied StemCell, Nagi Bioscience and GemPharmatech, among others.

  • Headquarter Sioux Center, United States
  • Employees 33 as on 31 Dec, 2022
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Exemplar Genetics Llc
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $238.92 K (USD), Grant

    Sep 23, 2014

  • Investors
    NIH

    & 2 more

  • Employee Count
    33

    as on Dec 31, 2022

  • Acquired by
    Precigen

    (Jan 26, 2015)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Exemplar Genetics

Exemplar Genetics offers a comprehensive portfolio of products and services, including Gene-edited Minipigs, Custom Models, Characterization Services, Housing Services, and Preclinical Services.

Product name locked
Category locked
Primary

Models for testing human diseases in preclinical settings.

Product name locked
Category locked
Locked

Gene-edited minipigs designed to meet specific client needs.

Product name locked
Category locked
Locked

Capabilities for evaluating minipig models in research contexts.

Product name locked
Category locked
Locked

Secure facilities for housing minipig projects securely.

Product name locked
Category locked
Locked

In-house services to accelerate clinical path development.

Funding Insights of Exemplar Genetics

Investors in Exemplar Genetics

Exemplar Genetics has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and Precigen.

All
Institutional
Investor Description Founded Year Domain Location
Drug discovery services are provided to the biopharma sector.
Locked Locked Locked
Public health and human services are overseen by HHS.
Locked Locked Locked
Gene and cell therapy biopharmaceutical company focused on immuno-oncology, autoimmune, and infectious diseases
Locked Locked Locked
Premium access

Investor details for Exemplar Genetics

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Exemplar Genetics

Investments
Premium access

Investment portfolio details for Exemplar Genetics

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Exemplar Genetics

Premium access

Detailed financials for Exemplar Genetics

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Exemplar Genetics Comparisons

Exemplar Genetics Primary company
Description
Genetic miniature pig models are developed for disease resea...
Location
Sioux Center, United States
Founded Year
2008
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
33
As of 2022
Premium access

Peer comparison for Exemplar Genetics

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Exemplar Genetics

Exemplar Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Interius Biotherapeutics, Applied StemCell, Nagi Bioscience and GemPharmatech, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Integrated solutions for next-generation antibody drug development are provided.
Locked Locked Locked
Developer of gene therapies for treating multiple diseases
Locked Locked Locked
Provider of animal and cell line models as tools for drug discovery and diagnostics
Locked Locked Locked
Developer of a organism on a chip based technology
Locked Locked Locked
Humanized models and drug screening technologies are developed for research.
Locked Locked Locked
In-vivo mouse models are developed for biomedical R&D applications.
Premium access

Detailed competitors of Exemplar Genetics

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Exemplar Genetics

Premium access

Complete news archive for Exemplar Genetics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Exemplar Genetics

Exemplar Genetics was founded in 2008.

Exemplar Genetics is headquartered in Sioux Center, United States. It is registered at Sioux Center, Iowa, United States.

As of Dec 31, 2022, the latest employee count at Exemplar Genetics is 33.

Exemplar Genetics was founded in 2008 and is based in Sioux Center, United States. Animal models using miniature pigs are developed by the company for conditions including heart disease, cystic fibrosis, cardiac arrhythmia, cancer, neuromuscular disorders, neurodegeneration, and nervous system issues, with a focus on Lonestar swine. Services offered encompass model development, regulatory support, and cloning within the biotechnology sector.

Exemplar Genetics's top competitors include Biocytogen, Applied StemCell and GemPharmatech.

Exemplar Genetics offers Gene-edited Minipigs, Custom Models, Characterization Services, Housing Services, and Preclinical Services.

Exemplar Genetics has 3 investors. Key investors include NIH, HHS, and Precigen.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available